Company Update (NYSE:MDT): GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation

[GlobeNewswire] – DUBLIN – April 7, 2015 – Medtronic plc (NYSE: MDT) today announced the first patient enrollment in the GOLD AF Registry, a first-of-its-kind, prospective, observational clinical study of its Phased Radiofrequency . . . → Read More: Company Update (NYSE:MDT): GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation Similar Articles: Market Update (NYSE:MDT): Medtronic Acquires Diabeter, Innovative Diabetes Care Provider Company Update (NYSE:MDT): Medtronic EVP & CFO Gary Ellis to Speak at Barclays Healthcare Conference Company Update: Medtronic Inc (NYSE:MDT) – Medtronic EVP & President Michael J. Coyle to Speak at Cowen Healthcare Conference